Hospital & Healthcare Management October 28, 2023
Content Team HHMGlobal

The MHRA, FDA, as well as Health Canada have jointly gone on to publish five guiding principles for machine learning-enabled medical device- MLMD manufacturers so as to develop predetermined change control plans- PCCPs.

The idea behind these guiding principles is to assist manufacturers of MLMDs by decreasing the regulatory requirements for reconsideration in case of specific modifications or improvements to their respective devices.

Building upon the 10 guiding principles for good machine learning practice, the 5 guiding principles for manufacturers of MLMD state that a properly constructed and carefully planned approach must be:

  1. Bounded and focused: Describing the particular modifications that manufacturers intend to make.
  2. Risk-based: The intent, design, and execution of a PCCP are guided by an approach...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
Your Earphones And Headphones As Health And Medical Devices
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace

Share This Article